Consequently, loss of SLF2 led to a striking acceleration and penetrance of B‐cell lymphomagenesis in vivo (Fig 2E), thus validating SLF2 as a functionally relevant tumor suppressor gene. This evidence concerns the gene SLF2 and neoplasm.